Overview
Muhammad Isa is an Oncologist practicing medicine in Fort Worth, Texas.
Dr. Isa is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Leukocytosis, Acute Lymphoblastic Leukemia (ALL), Thrombocytopenia, and Familial Colorectal Cancer.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1450 8th Ave, Fort Worth, TX 76104
1500 S Main St, Fort Worth, TX 76104
UT Southwestern-Bill And Rita Clements Advanced Medical Imaging Center
Farrukh Awan is a Hematologist and an Oncologist practicing medicine in Dallas, Texas. Dr. Awan is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Texas Oncology, P.A.
Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Inflammatory Breast Cancer, and Tissue Biopsy. Dr. O'shaughnessy is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.
Office
David Gerber is an Oncologist practicing medicine in Dallas, Texas. Dr. Gerber is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Endoscopy.
Frequently Asked Questions about Dr. Muhammad Isa
How do I make an appointment with Dr. Muhammad Isa?
You can book an appointment with Dr. Muhammad Isa by calling their office at 817-702-8300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Muhammad Isa a top-rated expert for Leukocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Muhammad Isa is classified as an Distinguished expert for Leukocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Muhammad Isa specialize in?
While Dr. Muhammad Isa is a Oncology, they have specific expertise in Leukocytosis, Acute Lymphoblastic Leukemia (ALL), and Thrombocytopenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Muhammad Isa accept my insurance?
Dr. Muhammad Isa accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 817-702-8300 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Isa isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- LeukocytosisDr. Isa isDistinguished. Learn about Leukocytosis.
- Advanced
- AngiosarcomaDr. Isa isAdvanced. Learn about Angiosarcoma.
- Familial Colorectal CancerDr. Isa isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Prostate CancerDr. Isa isAdvanced. Learn about Familial Prostate Cancer.
- Fibrolamellar CarcinomaDr. Isa isAdvanced. Learn about Fibrolamellar Carcinoma.
- Inflammatory Breast CancerDr. Isa isAdvanced. Learn about Inflammatory Breast Cancer.
- Laryngeal CancerDr. Isa isAdvanced. Learn about Laryngeal Cancer.
- Experienced
- Acute Mountain SicknessDr. Isa isExperienced. Learn about Acute Mountain Sickness.
- Acute Promyelocytic LeukemiaDr. Isa isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Isa isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Isa isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Isa isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer